Johnson & Johnson is expected to deliver preliminary late-stage trial results for its one-dose Covid vaccine candidate by the end of January. 

If its jab is proven to be safe and effective, the company aims to deliver at least 1 billion doses by the end of the year. 

https://www.cnbc.com/2021/01/11/johnson-johnson-covid-vaccine-analysts-are-cautiously-optimistic.html

By DC

Leave a Reply